Roth Raises Target on Enphase (ENPH) 50% Following Q2 Results and Outlook
Get Alerts ENPH Hot Sheet
Price: $109.17 --0%
Rating Summary:
25 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Rating Summary:
25 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Join SI Premium – FREE
Roth Capital affirms Enphase Energy (Nasdaq: ENPH) at Buy and raises its target price from $10 to $15 following Q2 results.
Analyst Philip Shen noted strong Q2 results from Enphase, with revs of $82 million and adjusted loss of 1 cent per share comparing with consensus estimates calling for revs of $71.1 million and loss of 2 cents per share.
Shen highlights three key takeaways from the results and commentary:
- (1) US revenue growth was up 50% YoY. International growth in Q2 continued nicely in both the UK and Australian markets. The mix of international revenues maintained its share of 15%;
- (2) ENPH is enabling the development of burgeoning financing models, such as no-money-down loans and PACE. We believe the company is in discussions with as many as a dozen additional financing partners. We expect these relationships to support demand growth for ENPH microinverters; and
- (3) While we believe the release of the commercial product could serve as another meaningful source of demand ahead, the timing remains unclear.
We increase our 2014 revenue forecast to $327mn (vs. prior consensus of $289mn and prior ROTHe of $291mn) to reflect the Q2 beat and management’s outlook in H2’14. Additionally, we increase GMs to 32.8% (vs. prior consensus of 32.4% and prior ROTHe of 31.7%). This results in our revised 2014 EPS estimate of -1c (vs. prior consensus of -3c and prior ROTHe of -6c).
For an analyst ratings summary and ratings history on Enphase Energy click here. For more ratings news on Enphase Energy click here.
Enphase Energy closed at $9.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Shopify (SHOP) to Overweight, 'Still Operating Leverage Left to Realize'
- Jefferies Downgrades ULTA Salon (ULTA) to Hold, 'Competition Intensifying & Prestige Refresh Needed'
- RBC Capital Starts Inspire Medical Systems (INSP) at Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!